-
261
The METTL3/TGF-β1 signaling axis promotes osteosarcoma progression by inducing MSC differentiation into CAFs via m6A modification
Published 2025-04-01“…Additionally, METTL3 was found to enhance the stability and expression of TGF-β1 mRNA through m6A modification, thereby facilitating the differentiation process of MSCs. …”
Get full text
Article -
262
-
263
Kinetics, equilibrium and thermodynamics studies on natural and heat treated clays for the removal of arsenate ions from aqueous solution
Published 2025-05-01“…Abstract This study investigates the adsorption properties of arsenic (As(V)) from aqueous solutions using natural clay (NAC) and heat-treated natural clay (HTNAC), highlighting its novelty and significance as a sustainable approach to arsenic removal. …”
Get full text
Article -
264
eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m6A modification
Published 2025-03-01“…Furthermore, eIF3a may be used to develop a potential strategy for treating sepsis.…”
Get full text
Article -
265
-
266
Liver-Targeting Nanoparticles GA-MSe@AR Treat NAFLD Through Dual Lipid-Lowering and Antioxidant Efficacy
Published 2025-04-01Get full text
Article -
267
PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma
Published 2025-02-01“…We enrolled 358 consecutive patients with lymphoma treated between 2012 and 2022, calculating the CACS from their pretreatment PET/CT. …”
Get full text
Article -
268
ALKBH1 knockdown promotes the growth, migration and invasion of HTR-8/SVneo cells through regulating the m5C modification PSMD14
Published 2025-03-01“…Abstract Preeclampsia (PE) is a pregnancy disease characterized by insufficient invasion and growth of trophoblast cells. adeno-associated virus encoding alkB homolog 1 (ALKBH1) is a demethylase in 5-methylcytosine (m5C) methylation modification. This study was performed to explore the role of ALKBH1 in hypoxia treated human extravasated trophoblast cells. …”
Get full text
Article -
269
Impact of Molding Temperature, Fiber Loading and Chemical Modifications on the Physicomechanical, and Microstructural Morphology Properties of Woven Kenaf Fiber/PLA Composites for...
Published 2024-12-01“…The consequences of processing variables such as fiber volume percent ranging from 25% to 50% and molding temperature range of 160°C to 180°C were also examined on the mechanical characteristics of developed composites and are validated using SEM analysis. Surface modifications result in improved tensile and flexural characteristics of developed treated kenaf/PLA composites. …”
Get full text
Article -
270
-
271
Compression force promotes the osteogenic differentiation of periodontal ligament stem cells by regulating NAT10-mediated ac4C modification of BMP2
Published 2024-12-01“…Methods Compressive force was used to treat PDLSCs to simulate orthodontic force treatment. …”
Get full text
Article -
272
-
273
Surface Modification of Sustainable Bio-Derived Areca Sheath Fibers for Enhanced Mechanical and Thermal Properties in Epoxy-Based Biocomposites: Spectroscopic, Thermogravimetric, a...
Published 2025-12-01“…The present study investigates the effect of chemical surface modification on the mechanical and thermal properties of bio-derived areca sheath fiber-reinforced epoxy biocomposites. …”
Get full text
Article -
274
Balloon and Glue Technique: A Modification of Distal Reinforcement to Prevent Anastomotic New Entry, Reducing Replacement Range in Acute Type A Aortic Dissection
Published 2025-03-01“…Ten patients with acute type A aortic dissection were treated using this technique. Postoperative computed tomography indicated no evidence of distal anastomotic entry tears. …”
Article -
275
-
276
-
277
-
278
Real-world palbociclib dose modifications and clinical outcomes in patients with HR+/HER2− metastatic breast cancer: A Flatiron Health database analysis
Published 2025-06-01“…Purpose: To examine the associations of palbociclib dose modifications with clinical outcomes of patients with HR+/HER2− metastatic breast cancer (MBC) treated with first-line (1L) palbociclib + aromatase inhibitor (AI) in routine practice. …”
Get full text
Article -
279
-
280